Huzhou Central Hospital
In research, Huzhou Central Hospital stands highest in Medicine (#1,725 of 10,443 worldwide), Health Sciences (#2,332 of 11,982 worldwide) and Life Sciences (#3,267 of 7,800 worldwide), 2022–2025. Relative to its size it is most specialised in Oncology and Pulmonary and Respiratory Medicine — Oncology is 7.7× its share of world research.
- World rank, 2022–2025
- #5,944 of 28,054 · #14,971 all time
- Rank in China
- #1,259 of 3,058
- Research works
- 1.3k ▲ 4% vs 2013–17
- Citations
- 10k 7.8 per fractional work
- Top-10% rate
- 21.1% record average 16.5%
- Open access
- 45% world 28%
What is Huzhou Central Hospital known for in research?
The fields where it stands highest, 2022–2025, ranked among every institution above the floor in each field.
| Field | World rank | Where that sits | Top-10% rate | Works | All time |
|---|---|---|---|---|---|
| MedicineField | #1,725 of 10,443 | 20.7% | 257 | #5652 | |
| Health SciencesDomain | #2,332 of 11,982 | 21.0% | 266 | #6693 | |
| Life SciencesDomain | #3,267 of 7,800 | 20.7% | 98 | #7450 | |
| Biochemistry, Genetics and Molecular BiologyField | #3,172 of 3,579 | 19.8% | 63 | #6737 |
Each strip is that field’s whole ranked pool, with the notch where Huzhou Central Hospital sits in it, in the colour of the band that rank falls in. The track under the rate is the rate itself: it carries no world mark, because the world rate differs by field (from about 6% to 21% in this record).
Which of those standings moved
The same fields on both windows: where it stood over the whole record, and where it stands in 2022–2025. The distance is the story, and it is the one thing the two rank columns above cannot show.
- Medicine#5,652 #1,725
- Health Sciences#6,693 #2,332
- Life Sciences#7,450 #3,267
- Biochemistry, Genetics and Molecular Biology#6,737 #3,172
A dot further right is a better standing. Fields it was not ranked in over the whole record are left out.
What does Huzhou Central Hospital specialise in?
Where its research is concentrated relative to its size: Oncology takes 7.7× the share of its output that it takes of world research.
- OncologySubfield · 33.9 works7.7×
- Pulmonary and Respiratory MedicineSubfield · 34.7 works5.8×
Location quotient, a volume reading rather than an impact one. It surfaces small, lopsided specialities.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Medicine, 3.4×. Every wedge is a field page.
- Medicine 3.4×
- Immunology and Microbiology 3.2×
- Biochemistry, Genetics and Molecular Biology 3.0×
- Pharmacology, Toxicology and Pharmaceutics 3.0×
- Neuroscience 2.1×
- Nursing 1.0×
- Dentistry 0.6×
- Health Professions 0.6×
- Psychology 0.3×
- Agricultural and Biological Sciences 0.2×
- Materials Science 0.2×
- Chemistry 0.2×
- Environmental Science 0.2×
- Computer Science 0.2×
- Engineering 0.1×
- Physics and Astronomy 0.1×
- Business, Management and Accounting 0.1×
- Decision Sciences 0.0×
- Social Sciences 0.0×
- Mathematics 0.0×
- Economics, Econometrics and Finance 0.0×
- Arts and Humanities 0.0×
Who are the top researchers at Huzhou Central Hospital?
Ranked on the composite score, Zhihong Ma and Licheng Dai lead among researchers whose main affiliation is Huzhou Central Hospital.
- 1 Zhihong Ma China · #1,377,901 worldwide 29 citations · 31 works
- 2 Licheng Dai China · #1,630,218 worldwide 1 citations · 15 works
Which keywords describe research at Huzhou Central Hospital?
By fractional works in 2022–2025, weighted toward what it does more of than the world: Inflammation, Cancer, Tumor Microenvironment, Epidemiology, Metastasis, Chemotherapy, Clinical Practice Guidelines and Immunity.
- Fibrosis
- Inflammatory Diseases
- Neuroprotection
- Neuroinflammation
- Prognostic Factors
- Prognosis
- Systemic Inflammatory Response
- Radiotherapy
- Chronic Kidney Disease
- Cell Death
- Immunotherapy
- Clinical Trials
- Quality of Life
- Gene Expression
- Biomarkers
- Treatment
- Clinical Practice Guidelines
- Chemotherapy
- Tumor Microenvironment
- Cancer
- Inflammation
- Epidemiology
- Oxidative Stress
- Metastasis
- Immunity
- Diagnosis
- Management
- Cardiovascular Disease
- Thrombosis
- Risk Factors
- Prognostic Markers
- Platelets
- Immune Response
- Neutrophil-to-Lymphocyte Ratio
- Critical Care
- Sepsis
- Angiogenesis
- Rehabilitation
- Adjuvant Therapy
- Biogenesis
Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Inflammation49▲ 6.0×70 topics
- Cancer43▲ 8.1×43 topics
- Epidemiology35▲ 2.2×78 topics
- Tumor Microenvironment25▲ 14×8 topics
- Oxidative Stress19▲ 3.0×45 topics
- Chemotherapy19▲ 6.8×19 topics
- Metastasis18▲ 13×11 topics
- Clinical Practice Guidelines16▲ 7.7×14 topics
- Immunity15▲ 9.6×9 topics
- Treatment15▲ 3.1×30 topics
- Diagnosis15▲ 4.0×29 topics
- Biomarkers14▲ 5.3×11 topics
- Management14▲ 4.6×20 topics
- Gene Expression13▲ 5.5×14 topics
- Cardiovascular Disease13▲ 3.0×29 topics
- Quality of Life12▲ 2.2×26 topics
- Thrombosis11▲ 10×6 topics
- Clinical Trials11▲ 4.2×15 topics
- Risk Factors11▲ 2.5×22 topics
- Immunotherapy11▲ 3.9×15 topics
- Prognostic Markers10▲ 25×3 topics
- Cell Death10▲ 11×6 topics
- Platelets10▲ 35×2 topics
- Chronic Kidney Disease9▲ 9.8×8 topics
- Immune Response9▲ 4.1×17 topics
- Radiotherapy9▲ 6.0×10 topics
- Neutrophil-to-Lymphocyte Ratio9▲ 54×1 topic
- Systemic Inflammatory Response9▲ 54×1 topic
- Critical Care9▲ 9.8×8 topics
- Prognosis9▲ 6.9×8 topics
- Sepsis9▲ 14×4 topics
- Prognostic Factors8▲ 4.8×11 topics
- Angiogenesis8▲ 6.2×14 topics
- Neuroinflammation8▲ 7.0×6 topics
- Rehabilitation8▲ 4.9×9 topics
- Neuroprotection7▲ 5.2×12 topics
- Adjuvant Therapy7▲ 13×2 topics
- Inflammatory Diseases6▲ 8.8×5 topics
- Biogenesis6▲ 8.7×3 topics
- Fibrosis6▲ 8.2×8 topics
Which research topics does Huzhou Central Hospital publish most on?
By volume in 2022–2025: Inflammatory Biomarkers in Disease Prognosis, Ferroptosis and cancer prognosis, Cancer Immunotherapy and Biomarkers and Gut microbiota and health.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Inflammatory Biomarkers in Disease Prognosis Oncology 9 works
- 2 Ferroptosis and cancer prognosis Pulmonary and Respiratory Medicine 6 works
- 3 Cancer Immunotherapy and Biomarkers Oncology 5 works
- 4 Gut microbiota and health Molecular Biology 4 works
- 5 Lung Cancer Diagnosis and Treatment Pulmonary and Respiratory Medicine 4 works
- 6 Sepsis Diagnosis and Treatment Epidemiology 3 works
- 7 Respiratory Support and Mechanisms Pulmonary and Respiratory Medicine 3 works
- 8 Acute Kidney Injury Research Nephrology 3 works
- 9 Gastric Cancer Management and Outcomes Pulmonary and Respiratory Medicine 3 works
- 10 Enhanced Recovery After Surgery Surgery 3 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Huzhou Central Hospital's research output changed?
Output in 2018–2022 was 4% higher than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Huzhou
- Huzhou University
- Huzhou Vocational and Technical College
- Third People's Hospital of Huzhou
- Zhejiang Institute of Freshwater Fisheries
- Huzhou Women and Children's Hospital
- Huzhou Academy of Agricultural Sciences
- Zhejiang Zhe Kuang Heavy Industries (China)
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.